Immunogenicity and efficacy of serogroup A and D bacterins against Pasteurella multocida in mice

Introduction Pasteurella multocida is a widespread respiratory pathogen in pigs, causing swine pneumonia and atrophic rhinitis, and the capsular serogroups A and D are the main epidemic serogroups in infected animals. This study investigated the protective effects of serogroup A and D bacterins against current circulating P. multocida strains, to better understand the immunity generated by bacterins. Method 13 serogroup A (seven A: L3 and six A: L6 strains) and 13 serogroup D (all D: L6 strains) P. multocida strains were isolated, and used as inactivated whole cell antigen to prepare P. multocida bacterins. Mice were immunized with these bacterins at 21-day interval and intraperitoneally challenged with the homologous and heterologous P. multocida strains, respectively. The antibody titer levels and immunization protective efficacy of vaccines were evaluated. Results All of the bacterins tested induced high titer levels of immunoglobulin G antibodies against the parental bacterial antigen in mice. Vaccination with the six A: L6 bacterins provided no protection against the parent strain, but some strains did provide heterologous protection against A: L3 strains. Vaccination with the seven A: L3 bacterins provided 50%–100% protection against the parent strain, but none gave heterologous protection against the A:L6 strains. Immunization with the thirteen D: L6 bacterins offered 60%–100% protection against the parent strain, and almost all D: L6 strains gave cross-protection. Discussion This study found that the cross-protectivity of serogroup A strains was poor, while serogroup D strains was effective, which provided some insights for P. multocida vaccine development.

[1]  A. Camarda,et al.  Spreading of Pasteurella multocida Infection in a Pet Rabbit Breeding and Possible Implications on Healed Bunnies , 2022, Veterinary sciences.

[2]  W. Liang,et al.  Pasteurella multocida capsular: lipopolysaccharide types D:L6 and A:L3 remain to be the main epidemic genotypes of pigs in China , 2021, Animal Diseases.

[3]  Zhan-Qin Zhao,et al.  Immune Protective Efficacy of China’s Traditional Inactivated and Attenuated Vaccines against the Prevalent Strains of Pasteurella multocida in Mice , 2021, Vaccines.

[4]  G. Cappellano,et al.  Nano-Microparticle Platforms in Developing Next-Generation Vaccines , 2021, Vaccines.

[5]  T. Johnson,et al.  Genomic diversity and molecular epidemiology of Pasteurella multocida , 2021, PloS one.

[6]  L. Johnson,et al.  A Rare Case of Bacteremic Community-Acquired Pneumonia Due to Pasteurella Multocida Presenting With Hemoptysis , 2021, Cureus.

[7]  L. Duan,et al.  Transcriptomic Analysis of High- and Low-Virulence Bovine Pasteurella multocida in vitro and in vivo , 2021, Frontiers in Veterinary Science.

[8]  P. Gupta,et al.  Development of novel iron-regulated Pasteurella multocida B: 2 bacterin and refinement of vaccine quality in terms of minimum variation in particle size and distribution vis-a-vis critical level of iron in media. , 2020, Microbial pathogenesis.

[9]  M. Ghorbanpoor,et al.  Effects of Selected Adjuvants on Immunogenicity and Protectivity of Pasteurella multocida Bacterin Vaccine in Chickens. , 2020, Archives of Razi Institute.

[10]  M. Shokrgozar,et al.  Pasteurella multocida Vaccine Candidates: A Systematic Review , 2020, Avicenna journal of medical biotechnology.

[11]  Z. Pan,et al.  Differences in pathogenicity and virulence-associated gene expression among Pasteurella multocida strains with high and low virulence in a lung tissue model. , 2019, Microbial pathogenesis.

[12]  Lizbeth Cahuayme-Zuniga,et al.  Acute epiglottitis due to Pasteurella multocida after contact with a feral cat , 2019, Proceedings.

[13]  L. Makrai,et al.  Virulence gene profiling and ompA sequence analysis of Pasteurella multocida and their correlation with host species. , 2019, Veterinary microbiology.

[14]  Jong Wan Kim,et al.  Characterisation of Pasteurella multocida isolates from pigs with pneumonia in Korea , 2019, BMC Veterinary Research.

[15]  R. Weiczner,et al.  Characterization of Pasteurella multocida strains isolated from human infections. , 2019, Comparative immunology, microbiology and infectious diseases.

[16]  K. Register,et al.  Pasteurellosis , 2019, Diseases of Swine.

[17]  K. VanderWaal,et al.  Global trends in infectious diseases of swine , 2018, Proceedings of the National Academy of Sciences.

[18]  S. Schwarz,et al.  Antimicrobial Resistance in Pasteurellaceae of Veterinary Origin , 2018, Microbiology spectrum.

[19]  R. Sharma,et al.  Virulence gene profiling of porcine Pasteurella multocida isolates of Assam , 2018, Veterinary world.

[20]  J. Boyce,et al.  The Myriad Properties of Pasteurella multocida Lipopolysaccharide , 2017, Toxins.

[21]  Qiao Xue,et al.  Occurrence of Pasteurella multocida among pigs with respiratory disease in China between 2011 and 2015 , 2017, Irish Veterinary Journal.

[22]  M. Tabatabaei,et al.  Occurrence of virulence-associated genes in Pasteurella multocida isolates obtained from different hosts. , 2016, Microbial pathogenesis.

[23]  J. Boyce,et al.  Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure. , 2016, Vaccine.

[24]  G. Fthenakis,et al.  Vaccination schedules in small ruminant farms. , 2015, Veterinary microbiology.

[25]  J. Boyce,et al.  Development of a Rapid Multiplex PCR Assay To Genotype Pasteurella multocida Strains by Use of the Lipopolysaccharide Outer Core Biosynthesis Locus , 2014, Journal of Clinical Microbiology.

[26]  J. Boyce,et al.  Structural analysis of lipopolysaccharide produced by Heddleston serovars 10, 11, 12 and 15 and the identification of a new Pasteurella multocida lipopolysaccharide outer core biosynthesis locus, L6. , 2014, Glycobiology.

[27]  J. Boyce,et al.  Pasteurella multocida Heddleston Serovar 3 and 4 Strains Share a Common Lipopolysaccharide Biosynthesis Locus but Display both Inter- and Intrastrain Lipopolysaccharide Heterogeneity , 2013, Journal of bacteriology.

[28]  B. Wilson,et al.  Pasteurella multocida: from Zoonosis to Cellular Microbiology , 2013, Clinical Microbiology Reviews.

[29]  E. Soriano-Vargas,et al.  Identification of Pasteurella multocida capsular types isolated from rabbits and other domestic animals in Mexico with respiratory diseases , 2012, Tropical Animal Health and Production.

[30]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[31]  J. Boyce,et al.  Pasteurella multocida Heddleston serovars 1 and 14 express different lipopolysaccharide structures but share the same lipopolysaccharide biosynthesis outer core locus. , 2011, Veterinary microbiology.

[32]  Huanchun Chen,et al.  Isolation, Antimicrobial Resistance, and Virulence Genes of Pasteurella multocida Strains from Swine in China , 2009, Journal of Clinical Microbiology.

[33]  L. Wieler,et al.  Virulence genotype of Pasteurella multocida strains isolated from different hosts with various disease status. , 2006, Veterinary microbiology.

[34]  J. Boyce,et al.  Genetic Organization of Pasteurella multocida cap Loci and Development of a Multiplex Capsular PCR Typing System , 2001, Journal of Clinical Microbiology.

[35]  J. Nielsen,et al.  Development of a typing system for epidemiological studies of porcine toxin-producing Pasteurella multocida ssp. multocida in Denmark. , 1999, Veterinary microbiology.

[36]  R. Rimler,et al.  Serogroup F, a new capsule serogroup of Pasteurella multocida , 1987, Journal of clinical microbiology.

[37]  P. Rebers,et al.  Fowl cholera: gel diffusion precipitin test for serotyping Pasteruella multocida from avian species. , 1972, Avian diseases.

[38]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[39]  W. Liang,et al.  A capsule/lipopolysaccharide/MLST genotype D/L6/ST11 of Pasteurella multocida is likely to be strongly associated with swine respiratory disease in China , 2017, Archives of Microbiology.

[40]  W. Liang,et al.  Experimental pathogenicity and complete genome characterization of a pig origin Pasteurella multocida serogroup F isolate HN07. , 2017, Veterinary microbiology.

[41]  J. Boyce,et al.  Pasteurella multocida , 2012, Current Topics in Microbiology and Immunology.

[42]  K. Kubatzky Pasteurella multocida and immune cells. , 2012, Current topics in microbiology and immunology.

[43]  M. Zheng,et al.  Serological identification of capsular antigens of Pasteurella multocida in China. , 1980 .

[44]  G. Carter The type specific capsular antigen of Pasteurella multocida. , 1952, Canadian journal of medical sciences.